Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells
Authors:
- Jung-Hwan YoonJYJung-Hwan Yoon
- Geum-Youn GwakGGGeum-Youn Gwak
- Hyo-Suk LeeHLHyo-Suk Lee
- Steven F. BronkSBSteven F. Bronk
- Nathan W. WerneburgNWNathan W. Werneburg
- Gregory J. GoresGGGregory J. Gores
- 1 November 2004
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 41 (5) , 808-814
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The epidermal growth factor receptor–tyrosine kinase: A promising therapeutic target in solid tumorsSeminars in Oncology, 2003
- Endocytosis of Epidermal Growth Factor Receptor Regulated by Grb2-mediated Recruitment of the Rab5 GTPase-activating Protein RN-treJournal of Biological Chemistry, 2002
- Cbl–CIN85–endophilin complex mediates ligand-induced downregulation of EGF receptorsNature, 2002
- COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cellsHepatology, 2002
- Endocytosis and SignalingCell, 2001
- Epidermal growth factor receptor signalingCurrent Biology, 2001
- Cloning and Characterization of a Novel Adaptor Protein, CIN85, That Interacts with c-CblBiochemical and Biophysical Research Communications, 2000
- Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell lineHepatology, 1997
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell, 1995
- Simultaneous detection of epidermal growth factor receptor (EGF‐R), epidermal growth factor (EGF) and ras p21 in cholangiocarcinoma by an immunocytochemical methodLiver International, 1988